Beyond the antibodies: serum metabolomic profiling of myasthenia gravis
- 1 August 2019
- journal article
- research article
- Published by Springer Nature in Metabolomics
- Vol. 15 (8) , 1-12
Abstract
Introduction Myasthenia gravis (MG) is a chronic, potentially debilitating autoimmune disease characterized by weakness and rapid fatigue of the voluntary muscles that worsens on exertion. Left untreated, MG symptoms may cause significant morbidity or even death. To date, no robust biological marker is available to follow the course of the disease. Therefore, new diagnostic approaches and biological markers are essential not only for improved diagnosis of the disease but for improved outcomes. Objectives The present study applied a two-control, multi-label metabolomics profiling approach as a potential strategy for the identification of biomarkers unique to myasthenia gravis (MG). Methods Metabolic analyses using acid- and dansyl-labelled serum from seropositive MG (n = 46), rheumatoid arthritis (RA) (n = 23) and healthy controls (HC) (n = 49) were performed on samples from adult patients presenting to the University of Alberta Hospital neuromuscular and rheumatology clinics. Comparisons between patients with MG vs. HC, and RA vs. HC were made using univariate and multivariate statistics. Results Serum biomarker patterns were statistically significantly different between groups. Principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA) models exhibited considerable distinction between all groups. Metabolites were then filtered to remove peak pairs common to both disease cohorts. Combined metabolite panels revealed clear separation between MG and HC for both library-matched (AUROC: 0.92 ± 0.03) and highest AUC patients (AUROC: 0.94 ± 0.05). Conclusion In patients presenting to the clinic with seropositive MG, metabolomic profiling is capable of distinguishing patients with disease from those without. These results provide an important first step towards a potential biomarker for improving MG identification.Keywords
This publication has 39 references indexed in Scilit:
- Proinflammatory and Immunoregulatory Roles of Eicosanoids in T CellsFrontiers in Immunology, 2013
- Muscle autoantibodies in myasthenia gravis: beyond diagnosis?Expert Review of Clinical Immunology, 2012
- MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysisNucleic Acids Research, 2012
- Dynamics of arachidonic acid mobilization by inflammatory cellsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic PopulationPLOS ONE, 2010
- Bile acids and signal transduction: Role in glucose homeostasisCellular Signalling, 2008
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- The positive false discovery rate: a Bayesian interpretation and the q-valueThe Annals of Statistics, 2003
- Physiology and pathophysiology of organic acids in cerebrospinal fluidJournal of Inherited Metabolic Disease, 1993